Ezra D, Iaina A, Kapuler S, Almog S, Eshkol A, Gavendo S, Eliahou H E, Gafni J
Miner Electrolyte Metab. 1982 Jun;7(6):285-91.
The effects of chlorothiazide and furosemide on serum potassium were studied in fasting anuric patients maintained by chronic hemodialysis and compared to a control period when no drug was administered. Serum potassium levels were significantly lower following oral chlorothiazide (15 mg/kg body weight) than during the control period. After intravenous furosemide (1 mg/kg body weight), potassium levels were midway between those of the chlorothiazide and control periods, but statistical significance was not attained. Comparing the three study periods, there were no significant differences in the changes in body weight, blood pressure, blood pH, hematocrit, urea, glucose, sodium, albumin, insulin, plasma renin activity and aldosterone. This suggests that an extrarenal action of chlorothiazide on the cell membrane promotes cellular uptake of potassium.
在接受慢性血液透析维持治疗的禁食无尿患者中,研究了氯噻嗪和呋塞米对血清钾的影响,并与未给药的对照期进行了比较。口服氯噻嗪(15mg/kg体重)后血清钾水平显著低于对照期。静脉注射呋塞米(1mg/kg体重)后,钾水平介于氯噻嗪期和对照期之间,但未达到统计学显著性。比较三个研究期,体重、血压、血液pH值、血细胞比容、尿素、葡萄糖、钠、白蛋白、胰岛素、血浆肾素活性和醛固酮的变化无显著差异。这表明氯噻嗪对细胞膜的肾外作用促进了细胞对钾的摄取。